A Novel Allosteric Inhibitor Targeting IMPDH at Y233 Overcomes Resistance to Tyrosine Kinase Inhibitors in LymphomaNagarajan Pattabiraman, Johnvesly Basappa|Preprints.org|2025Cited by 1
A Novel Allosteric Inhibitor Targeting IMPDH at Y233 Overcomes Resistance to Tyrosine Kinase Inhibitors in LymphomaNagarajan Pattabiraman, Johnvesly Basappa|Cancers|2025Cited by 0